CAPILLARY Capillary Technologies India Q1 FY27 results (Apr–Jun 2026) and concall
Capillary Technologies delivered robust Q1 FY27 results, with revenue growing 43% YoY to INR256 crores and EBITDA soaring 132% YoY to INR44 crores. This performance was driven by a strong 111% Net Retention Rate and the successful integration of the SessionM acquisition, which is already profitable. Despite a reported PAT loss due to a cyber-fraud incident, the normalized PAT was positive, reflecting underlying operational strength and strategic progress in AI-led migrations and customer expansion.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q1 FY27: revenue up 51.9%, net profit up 251.8% against the same quarter last year.
| Line item | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|
| Revenue | 42 | 49 | 42 | 47 | 58 +37% | 65 +31% | 64 +52% |
| EBITDA | 9 | 15 | 6 | 8 | 10 +16% | 16 +5% | 15 +167% |
| Net profit | 0 | 7 | -5 | -3 | 1 +950% | 10 +40% | 8 +252% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
